Driving performance of Huntington’s disease gene carriers
Objective: To investigate if differences in driving performance between Huntington's disease (HD) gene carriers and healthy individuals can be detected with a driving simulator. Furthermore,…Malignant gliomas in patients with Huntington’s disease
Objective: Discuss the presentation of glioblastoma multiforme in patients with Huntington’s disease Background: Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by a trinucleotide…Evaluation of motor impulsivity in Huntington Disease with a choice reaction time task and brain metabolic (PET 18FDG) imaging
Objective: To describe motor impulsivity in early Huntington disease (HD) with electromyographic (EMG) recordings during a choice reaction time task (Simon Task) and brain metabolic…Assessing the potential of EEG as a biomarker in Huntington’s disease using machine learning automatic classification
Objective: To construct an automatic classifier distinguishing healthy controls from Huntington’s disease (HD) gene carriers using quantitative electroencephalography (qEEG) and to derive qEEG features that…Exploration of insight competence in Huntington’s disease supplemental to a cognitive debriefing study for the FuRST2.0 rating scale
Objective: Evaluate insight of functional impairment in premanifest and early-manifest Huntington’s disease (HD). Background: Following the guidelines of the US Food and Drug Administration Clinical…Late onset Huntington’s disease in an Argentinian cohort
Objective: To describe the prevalence, clinical and molecular characteristics of a series of LOHD patients in an Argentinean cohort. Background: Late onset Huntington’s disease (LOHD)…On the hunt for a link between genetically confirmed Huntington’s disease and Amyotrophic Lateral Sclerosis
Objective: To characterise the clinical and pathologic findings of Huntington’s disease (HD) and coincident amyotrophic lateral sclerosis (ALS). Background: A 66 year old man presented…The distinct cognitive syndromes of Huntington’s disease: A two-year follow-up study
Objective: To explore if patients can be clustered into different groups based on dissimilar patterns of cognitive deterioration in a 2-year follow-up; to study the…Cerebrospinal fluid flow dynamics in Huntington’s disease evaluated by phase contrast MRI
Objective: To elucidate the dynamics of CSF flow through the neuraxis in Huntington’s disease (HD) using phase contrast magnetic resonance imaging (PCMRI). Background: HD is…Submandibular gland is a suitable tissue for alpha synuclein pathology in Parkinson’s disease
Objective: To validate the role of α-synuclein (AS) pathology in submandibular gland (SMG) as a biomarker for Parkinson disease (PD). Background: The pathologic hallmark of…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.